These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 34394093

  • 1. High Frequency Occult Hepatitis B Virus Infection Detected in Non-Resolved Donations Suggests the Requirement of Anti-HBc Test in Blood Donors in Southern China.
    Ye X, Zhao Y, Li R, Li T, Zheng X, Xiong W, Zeng J, Xu M, Chen L.
    Front Immunol; 2021; 12():699217. PubMed ID: 34394093
    [Abstract] [Full Text] [Related]

  • 2. High-Frequency Notable HBV Mutations Identified in Blood Donors With Occult Hepatitis B Infection From Heyuan City of Southern China.
    Ye X, Liu L, Chen L, Nie X, Huang L, Ye D, Zeng J, Li T, Li B, Xu M, Chen L.
    Front Immunol; 2022; 13():754383. PubMed ID: 35634299
    [Abstract] [Full Text] [Related]

  • 3. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 4. Blood donor testing for hepatitis B virus in the United States: is there a case for continuation of hepatitis B surface antigen detection?
    Dodd RY, Nguyen ML, Krysztof DE, Notari EP, Stramer SL.
    Transfusion; 2018 Sep; 58(9):2166-2170. PubMed ID: 30144082
    [Abstract] [Full Text] [Related]

  • 5. What is the meaning of a nonresolved viral nucleic acid test-reactive minipool?
    Wang L, Chang L, Xie Y, Huang C, Xu L, Qian R, Zhu H, He Y, Li J, Huang H, Li W, Zhang K, Zhang R, Xie J, Sun Y, Li J.
    Transfusion; 2015 Feb; 55(2):395-404. PubMed ID: 25125223
    [Abstract] [Full Text] [Related]

  • 6. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
    van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL.
    Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
    [Abstract] [Full Text] [Related]

  • 7. Cost-benefit analysis of serological and nucleic acid testing for hepatitis B virus in blood donors in southern China.
    Ye X, Xiong W, Xu X, Zeng J, Xie H, Li B, He B, Chen L, Mo Q.
    BMC Infect Dis; 2024 Sep 02; 24(1):909. PubMed ID: 39223540
    [Abstract] [Full Text] [Related]

  • 8. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?
    Niederhauser C, Mansouri Taleghani B, Graziani M, Stolz M, Tinguely C, Schneider P.
    Swiss Med Wkly; 2008 Mar 08; 138(9-10):134-41. PubMed ID: 18330733
    [Abstract] [Full Text] [Related]

  • 9. Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany.
    Houareau C, Offergeld R.
    Vox Sang; 2019 Jul 08; 114(5):459-466. PubMed ID: 30968958
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase.
    Ren FR, Wang JX, Huang Y, Yao FZ, Lv YL, Li JL, Wen GX, Wen XQ, Liu J, Dong XD, Ma HL, Zhou ZM, Bi XH, Tu L, King M, Nelson K, Ness P, Shan H.
    Transfusion; 2011 Dec 08; 51(12):2588-95. PubMed ID: 21682731
    [Abstract] [Full Text] [Related]

  • 11. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
    Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA.
    Transfusion; 2005 Aug 08; 45(8):1247-57. PubMed ID: 16078909
    [Abstract] [Full Text] [Related]

  • 12. Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy.
    Spreafico M, Berzuini A, Foglieni B, Candotti D, Raffaele L, Guarnori I, Colli A, Maldini FF, Allain JP, Prati D.
    J Hepatol; 2015 Nov 08; 63(5):1068-76. PubMed ID: 26116791
    [Abstract] [Full Text] [Related]

  • 13. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K.
    Transfusion; 2007 Jul 08; 47(7):1197-205. PubMed ID: 17581154
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
    Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group.
    Transfusion; 2014 Aug 08; 54(8):2084-91. PubMed ID: 24650170
    [Abstract] [Full Text] [Related]

  • 16. NAT for HBV and anti-HBc testing increase blood safety.
    Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E.
    Transfusion; 2002 Jul 08; 42(7):869-75. PubMed ID: 12375659
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP.
    Transfus Clin Biol; 2004 Feb 08; 11(1):26-32. PubMed ID: 14980546
    [Abstract] [Full Text] [Related]

  • 19. Molecular characteristics of HBV infection among blood donors tested HBsAg reactive in a single ELISA test in southern China.
    Ye X, Li T, Li R, Liu H, Zhao J, Zeng J.
    BMC Infect Dis; 2021 Jan 19; 21(1):83. PubMed ID: 33468062
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
    Stramer SL, Notari EP, Krysztof DE, Dodd RY.
    Transfusion; 2013 Oct 19; 53(10 Pt 2):2449-58. PubMed ID: 23607261
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.